Compounded GLP-1 provider guide
Compounded GLP-1 is semaglutide or tirzepatide produced by a compounding pharmacy rather than the brand-name manufacturer (Novo Nordisk or Eli Lilly). The trust questions here are different from branded telehealth: you're vetting the pharmacy, the marketing claims, and the regulatory posture, not the drug itself.
This category guide and its profile ratings reflect earlier checks. Each profile shows its own full-review date; commercial terms have separate source dates. Designing Longevity is a founder-led editorial publication. Our content is not medically reviewed. Confirm current details directly before choosing.
Honest context
Compounded drugs are not FDA-approved. The FDA approves brand-name semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) but not compounded versions, even when the active ingredient is the same. The FDA has specifically warned that telehealth providers cannot market compounded GLP-1 as equivalent to the FDA-approved brands. That is a real regulatory boundary, not a marketing footnote, and it shapes how every provider in this category has to operate.
All Compounded GLP-1 providers
Profiles are alphabetical. Ratings, where shown, belong to the earlier review date on each profile. A withdrawn rating is hidden. Read the dated sources and confirm current program details directly.
Eden
Vertically-integrated GLP-1 telehealth with notable customer-service caveats
Eden has the most ambitious supply-chain story in our cohort, they own the pharmacy that fills your prescription, with a publicized per-lot testing program. The catch is the gap between the marketing and the operational record. We list Eden because the structural advantages are real, but we score the experience-side dimensions honestly.
Full profile last checked May 1, 2026. Program terms may have separate check dates.
Current pricing needs a fresh check.
No financial relationshipHenry Meds
The full profile retains its earlier verification date. Check the dated program terms below before choosing.
The full profile retains its earlier verification date. Check the dated program terms below before choosing.
Full profile last checked May 1, 2026. Program terms may have separate check dates.
Current pricing needs a fresh check.
No financial relationshipMochi Health
Program terms need a fresh check
Current program terms need a fresh check. Read the dated public record and ask for a written quote.
Program needs a fresh check. Earlier public record checked Oct 9, 2026.
Earlier broad provider rating withdrawn after the October 9, 2026 public-record correction. The program-terms checklist has separate dated sources.
Get a current quote
No financial relationshipRo
Program terms need a fresh check
Current program terms need a fresh check. Read the dated public record and ask for a written quote.
Program needs a fresh check. Earlier public record checked May 1, 2026.
Get a current quote
No financial relationshipTrimRx
LegitScript-certified compounded GLP-1 telehealth
Strongest compliance posture in our initial GLP-1 cohort.
Full profile last checked Apr 30, 2026. Program terms may have separate check dates.
Current pricing needs a fresh check.
No financial relationshipWhat to look for in Compounded GLP-1
Questions to bring to a provider. These are checks you can ask about, not a quality ranking or a medical assessment.
01What exact medicine would the quote cover?
Ask for the product name, form, prescribed dose and whether it is an approved brand or a compounded preparation. For a compounded prescription, ask the prescriber why an approved medicine cannot meet the specific medical need.
02What is the full amount due now and at renewal?
Request a written breakdown of medication, any separate program fee, shipping and other charges. Check the introductory period, billing schedule and later-dose price rather than relying on a starting-price headline.
03Who prescribes and which pharmacy dispenses?
Ask for the clinician and dispensing pharmacy names, the relevant state licenses and a way to check them. A business badge or the absence of a warning letter does not establish clinical quality or suitability for you.
04What happens if the prescription or plan changes?
Check follow-up access, refill terms, cancellation deadlines and the refund policy. Ask whether medication billing is handled by a separate pharmacy and which charges can continue after stopping medication.
Head-to-head comparisons in this category
Each comparison shows its evidence dates and explains where a difference, tie, or open question remains.
Eden vs Henry Meds
Compare Eden and Henry Meds using dated program terms and clearly labeled evidence limits.
Read comparisonHenry Meds vs TrimRx
Compare Henry Meds and TrimRx using dated program terms and clearly labeled evidence limits.
Read comparisonMochi Health vs Eden
Compare Mochi Health and Eden using dated program terms and clearly labeled evidence limits.
Read comparisonMochi Health vs Henry Meds
Compare Mochi Health and Henry Meds using dated program terms and clearly labeled evidence limits.
Read comparisonMochi Health vs Ro
Compare Mochi Health and Ro using dated program terms and clearly labeled evidence limits.
Read comparisonMochi Health vs TrimRx
Compare Mochi Health and TrimRx using dated program terms and clearly labeled evidence limits.
Read comparisonRo vs Eden
Compare Ro and Eden using dated program terms and clearly labeled evidence limits.
Read comparisonRo vs Henry Meds
Compare Ro and Henry Meds using dated program terms and clearly labeled evidence limits.
Read comparisonTrimRx vs Eden
Compare TrimRx and Eden using dated program terms and clearly labeled evidence limits.
Read comparisonTrimRx vs Ro
Compare TrimRx and Ro using dated program terms and clearly labeled evidence limits.
Read comparisonFrequently asked
The questions readers actually have about Compounded GLP-1 providers.
Are compounded GLP-1 medications safe?
Compounded GLP-1 drugs are not FDA-approved. FDA does not review them for safety, effectiveness or quality before they are marketed, and a pharmacy license or accreditation does not establish equivalence to an approved medicine. FDA recommends compounded drugs only when an FDA-approved drug cannot meet a patient's medical needs. Discuss the specific product with a licensed prescriber and pharmacist; this directory does not establish that it is safe for you.
Is compounded GLP-1 still legal after the FDA shortage list ended?
Not automatically. A prescription and a pharmacy license alone do not establish compliance. FDA's April 1, 2026 policy update says semaglutide and tirzepatide are on neither its shortage list nor the 503B bulks list. Section 503A restricts routine compounding of essentially copies of commercially available drugs; a prescriber-documented change that makes a significant difference for an individual patient is one relevant exception. Check current FDA guidance and discuss the specific prescription with a licensed prescriber and pharmacist.
How do I know if a compounded GLP-1 provider is legit?
Check three independent signals: LegitScript Healthcare Merchant certification (required for Google and Meta advertising), BBB profile rating and accreditation tenure, and FDA warning-letter database for the operating entity. None of those alone proves a provider is trustworthy, but if all three point the same direction, you have a reasonable baseline. We also weight whether the compounding pharmacy is named per fill, whether per-batch certificates of analysis are published, and whether cancellation requires a phone call vs an in-app flow.
What's the difference between compounded oral and injectable GLP-1?
Injectable compounded semaglutide and tirzepatide are the same delivery route as the brand-name injectables (subcutaneous weekly), and clinical evidence on the injectable form is well-established. Oral compounded forms (tablets or troches) are a relatively new product line and the clinical evidence base for oral compounded versions is meaningfully thinner than for injectables. Henry Meds is among the few cohort providers offering oral tirzepatide tablets; if you specifically want oral, options narrow. We treat oral compounded GLP-1 as more experimental than injectable, even though both use the same active ingredient.
Related reading
Where else to look on the site for context on this category.
GLP-1 Cost Calculator
Dated facts, source links and limitations.
Regulatory timeline 2025-2026
FDA enforcement waves, Eli Lilly v. Henry Meds, and the Novo Nordisk-Hims dispute that reshaped this category.
Branded GLP-1 (Wegovy, Ozempic, Zepbound) instead
Dated facts, source links and limitations.
Provider vetting methodology
The full six-dimension rubric we score every provider on.
Semaglutide explainer
What the active ingredient is, how it works, evidence base.
Tirzepatide explainer
The dual GLP-1/GIP agonist, with mechanism and evidence.
Edited by Designing Longevity Editorial. Earlier category review checked May 1, 2026.
Spot something out of date or wrong? Let us know.
Back to provider directory